Read + Share
Cromwell EA, Ostrenga JS, Sanders DB, Morgan W, et al. Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with
cystic fibrosis with no F508del variant in the USA. Eur Respir J 2024;64:2401146.
PMID: 39227072
|
 |
|
Cromwell EA, Ostrenga JS, Sanders DB, Morgan W, et al. Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with
cystic fibrosis with no F508del variant in the USA. Eur Respir J 2024;64:2401146.
PMID: 39227072
|
|
|
|